Double maintains 1 strategies that include DCTH - Delcath Systems, Inc.
Current Value
$12.231 Year Return
Current Value
$12.231 Year Return
Yahoo
QUEENSBURY, N.Y., April 28, 2025--Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug Administration (FDA) has completed its 30-day review of the Company's Investigational New Drug (IND) application for a Phase 2 clinical trial evaluating HEPZATO™ in combination with standard of care (SOC) for liver-dominant metastatic breast cancer (mBC). With the FDA's review compl
SeekingAlpha
Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find out why IMCR stock is a hold.
Yahoo
QUEENSBURY, N.Y., April 24, 2025--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 8, 2025, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2025.
Yahoo
QUEENSBURY, N.Y., April 09, 2025--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of a comparative analysis from the randomized cohort of the Company’s Phase 3 FOCUS study in Annals of Surgical Oncology. The study, titled "An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma,
SeekingAlpha
Delcath's Q4 sales exceeded expectations due to HEPZATO KIT adoption. Discover insights into its profitability, CHOPIN trial impact & 2025 sales forecast.
Yahoo
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its board of directors, effective March 26, 2025. Mr. Michel is Chief Executive Officer of Delcath Systems (Nasdaq: DCTH), a commercial-stage interventional oncology company. “We are excited to welcome Gerard to the Beta Bionics Board,” said Sean Saint, P
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBIL | -0.05% | $771.56M | 0.15% |
ULST | 0.06% | $622.03M | 0.2% |
UTWO | 0.10% | $385.68M | 0.15% |
SUB | -0.32% | $9.30B | 0.07% |
IBTH | 0.64% | $1.51B | 0.07% |
IBTF | -0.79% | $2.13B | 0.07% |
STPZ | -0.85% | $447.16M | 0.2% |
MEAR | -0.90% | $1.01B | 0.25% |
SHV | -0.91% | $22.70B | 0.15% |
BSMW | -1.02% | $102.14M | 0.18% |
VGSH | -1.39% | $23.06B | 0.03% |
FXY | -1.61% | $958.45M | 0.4% |
USFR | 1.79% | $18.59B | 0.15% |
BILZ | 1.79% | $835.83M | 0.14% |
TBIL | 1.85% | $5.69B | 0.15% |
SHYD | 1.93% | $317.63M | 0.35% |
SHM | 2.09% | $3.38B | 0.2% |
SMMU | 2.14% | $800.46M | 0.35% |
SMB | 2.20% | $264.64M | 0.07% |
HYMB | 2.23% | $2.54B | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALHC | 0.06% | $3.32B | +218.82% | 0.00% |
KC | -0.07% | $3.73B | +300.29% | 0.00% |
CMS | 0.18% | $21.83B | +19.10% | 2.85% |
AGL | -0.30% | $1.62B | -18.63% | 0.00% |
CYD | 0.34% | $625.13M | +85.45% | 2.39% |
PTGX | 0.35% | $2.76B | +76.16% | 0.00% |
SYPR | -0.38% | $37.98M | +20.44% | 0.00% |
T | 0.38% | $198.40B | +64.33% | 4.01% |
NEOG | 0.39% | $1.12B | -58.63% | 0.00% |
BGS | -0.40% | $538.93M | -40.26% | 11.13% |
VZ | -0.42% | $182.56B | +11.23% | 6.22% |
CCRN | -0.42% | $443.59M | -19.18% | 0.00% |
VIPS | 0.43% | $5.89B | -15.63% | 3.43% |
VIV | 0.51% | $15.58B | +3.22% | 0.00% |
MDLZ | 0.53% | $87.93B | -3.73% | 2.69% |
AWK | -0.55% | $28.56B | +16.26% | 2.08% |
AEP | 0.57% | $59.85B | +21.86% | 3.35% |
CNC | -0.59% | $29.56B | -20.07% | 0.00% |
AGRO | 0.61% | $918.50M | -14.60% | 3.76% |
IRWD | 0.65% | $147.55M | -89.01% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALC | 42.81% | $47.57B | +22.63% | 0.27% |
HBM | 42.65% | $2.56B | -12.50% | 0.19% |
ONON | 40.53% | $15.45B | +45.75% | 0.00% |
HROW | 38.76% | $917.13M | +134.96% | 0.00% |
CNNE | 38.69% | $1.11B | -10.09% | 2.66% |
BX | 38.62% | $161.80B | +12.10% | 2.95% |
TECK | 38.53% | $17.19B | -28.85% | 1.01% |
BN | 38.35% | $81.05B | +29.84% | 0.60% |
FCX | 38.11% | $52.29B | -25.36% | 1.60% |
SOFI | 37.47% | $13.81B | +78.97% | 0.00% |
SONY | 37.13% | $152.32B | +50.33% | 1.32% |
MKSI | 37.06% | $4.83B | -39.29% | 1.20% |
PSFE | 36.84% | $911.95M | +5.13% | 0.00% |
BNT | 36.64% | $10.87B | +29.90% | 0.00% |
ARES | 36.63% | $33.27B | +13.09% | 2.51% |
MAC | 36.50% | $3.70B | +6.16% | 4.59% |
GTES | 36.15% | $4.91B | +15.74% | 0.00% |
XPER | 35.96% | $330.46M | -31.83% | 0.00% |
SW | 35.87% | $21.12B | -12.44% | 2.50% |
DHR | 35.75% | $140.78B | -20.31% | 0.56% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -30.57% | $155.82M | 0.59% |
BTAL | -29.37% | $443.78M | 1.43% |
VIXY | -26.98% | $195.31M | 0.85% |
IVOL | -16.23% | $316.60M | 1.02% |
XONE | -9.72% | $581.95M | 0.03% |
BILS | -9.69% | $3.92B | 0.1356% |
UNG | -9.09% | $458.43M | 1.06% |
FTSD | -8.46% | $215.87M | 0.25% |
USDU | -8.36% | $196.68M | 0.5% |
XHLF | -7.16% | $1.32B | 0.03% |
TBLL | -7.03% | $2.54B | 0.08% |
BIL | -6.65% | $47.70B | 0.1356% |
UUP | -6.11% | $281.17M | 0.77% |
SPTS | -5.75% | $6.00B | 0.03% |
CTA | -4.73% | $1.02B | 0.76% |
BSCP | -4.64% | $3.57B | 0.1% |
SGOV | -4.45% | $44.86B | 0.09% |
IBMO | -4.29% | $508.86M | 0.18% |
IBTG | -4.26% | $1.85B | 0.07% |
SHYM | -3.99% | $317.02M | 0.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CGBL | 41.81% | $2.00B | 0.33% |
CWB | 41.18% | $3.67B | 0.4% |
CGXU | 40.84% | $3.39B | 0.54% |
QQQJ | 40.38% | $575.79M | 0.15% |
PFUT | 40.27% | $328.90M | 0.65% |
AOM | 40.01% | $1.48B | 0.15% |
FTC | 39.74% | $1.04B | 0.6% |
VBK | 39.69% | $17.04B | 0.07% |
FTLS | 39.62% | $1.92B | 1.38% |
PPI | 39.61% | $49.89M | 0.78% |
VT | 39.59% | $43.14B | 0.06% |
GDIV | 39.54% | $233.31M | 0.5% |
CPRJ | 39.47% | $47.36M | 0.69% |
FCTR | 39.42% | $60.89M | 0.65% |
KJUL | 39.33% | $111.90M | 0.79% |
ACWI | 39.32% | $20.23B | 0.32% |
VXF | 39.31% | $19.94B | 0.05% |
VB | 39.29% | $57.57B | 0.05% |
DFAW | 39.28% | $666.55M | 0.25% |
CGGO | 39.25% | $5.29B | 0.47% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HSY | -12.70% | $33.85B | -14.68% | 3.30% |
PARAA | -10.41% | $15.23B | -13.03% | 0.88% |
CBOE | -9.79% | $23.16B | +27.04% | 1.12% |
VSTA | -8.74% | $365.72M | +20.79% | 0.00% |
FMTO | -7.36% | $58.37M | -99.92% | 0.00% |
CIG.C | -7.35% | $2.42B | +11.15% | 0.00% |
VSA | -6.76% | $4.19M | -76.25% | 0.00% |
CI | -5.94% | $90.87B | -2.71% | 1.65% |
ED | -5.79% | $40.54B | +18.17% | 2.97% |
FIZZ | -5.76% | $4.05B | -1.23% | 0.00% |
KMB | -5.29% | $43.09B | -4.86% | 3.76% |
COR | -5.03% | $56.32B | +29.23% | 0.72% |
PARA | -4.72% | $7.81B | -15.95% | 1.70% |
CME | -4.53% | $99.87B | +33.56% | 3.77% |
OCX | -3.99% | $88.66M | +11.53% | 0.00% |
CHD | -3.96% | $22.74B | -12.75% | 1.23% |
CYCN | -3.82% | $8.94M | +17.02% | 0.00% |
BTCT | -3.57% | $20.96M | +80.52% | 0.00% |
PSQH | -3.48% | $77.25M | -55.00% | 0.00% |
FENC | -3.39% | $168.60M | -32.78% | 0.00% |